AMASA-9 Meeting, Addis Ababa,10 - 12th November 2013

M. Iqbal ParkerAcademy of Science of South AfricaDirector: ICGEB Cape Town

Stimulating the Bio-Economy in Africa

Biotechnology Sectors in Emerging Markets

ALL Biotechnologies

Conventional Biotechnology

Trypsin

Recombinant Pro Insulin

RecombinantInsulin

80+ Signatory States, 60+ Member States, 3 Components:Trieste (Italy) - New Delhi (India) - CapeTown (South Africa)

and a network of 40+ Affiliated Centres

Developing knowledge

CapeTown, South Africa

New Delhi, India

Trieste, Italy

ICGEB: an intergovernmental ICGEB: an intergovernmental organizationorganization

Production of Bio-Similars

What does the International Centre for Genetic Engineering

and Biotechnology offer ?

INSTRUMENTS OF ACTION

Workshops and Courses

Member CountryResearch Laboratories

Member CountryResearch Laboratories

ICGEB Components Basic and Applied Research

Institutional and Scientific

Services

TechnologyTransfer Research Grants

Pre- and Post-Doc Fellowships

Trained Scientists

(€ 18,000)

(€ 30,000)

(€ 20,000)

Technology Transfer opportunities

• Recombinant Human Interferons• Recombinant Human erythropoietin• Recombinant Human Insulin• Recombinant Human GCSF• Pegylated Interferon• Pegylation Reagent• Etc

What should be done ?

Figure 1: Global venture funding of private biotech companies 2000-2013

A RESEARCH, DEVELOPMENT AND INNOVATION STRATEGY TO

STRENGTHEN THE BIOECONOMY

DRAFT DOCUMENT

Thank YouThank You

International Centre for Genetic Engineering and BiotechnologyInternational Centre for Genetic Engineering and Biotechnology